Large gap with delayed quotes
|
Last quote
07/01/2025
-
22:15:00
|
Bid
07/01/2025 -
22:00:00
|
Bid Volume |
Ask
07/01/2025 -
22:00:00
|
Ask Volume |
|---|---|---|---|---|
|
2.38
+0.08
(
+3.48% )
|
2.38
|
112,500 |
2.39
|
44,300 |
Analysis date: 27.06.2025
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 30.05.2025.
Interest
Very weak
Very weak
One star since 30.05.2025.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 04.03.2025 at a price of 3.17.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Negative
Negative
The forty day technical trend is negative since 09.05.2025.
4wk Rel Perf
-0.66%
-0.66%
The four-week dividend-adjusted performance versus SP500 is .
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.17%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 8.68%.
Mkt Cap in $bn
0.96
0.96
With a market capitalization <$2bn, AGILON HEALTH is considered a small-cap stock.
G/PE Ratio
0.53
0.53
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
-18.88
-18.88
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
10.02%
10.02%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
16
16
Over the last seven weeks, an average of 16 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
-10
-10
For 1% of index variation, the stock varies on average by -0.10%.
Correlation
-0.02
-0.02
Stock movements are strongly independent of index variations, with an even divergent trend.
Value at Risk
1.53
1.53
The value at risk is estimated at USD 1.53. The risk is therefore 66.29%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
26.10.2021
26.10.2021